Davida Cory News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Davida cory. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Davida Cory Today - Breaking & Trending Today

Eiger BioPharmaceuticals (EIGR) to Release Earnings on Friday

Eiger BioPharmaceuticals (NASDAQ:EIGR – Get Rating) will be releasing its earnings data on Friday, May 12th. Eiger BioPharmaceuticals (NASDAQ:EIGR – Get Rating) last released its earnings results on Thursday, March 16th. The biotechnology company reported ($0.57) earnings per share for the quarter. Eiger BioPharmaceuticals had a negative return on equity of 115.96% and a negative […] ....

Glenns Jeffrey , Davida Cory , Capital Management , Renaissance Technologies , Barclays Plc , Morgan Stanley , Eiger Biopharmaceuticals Inc , Millennium Management , Eiger Biopharmaceuticals , Get Rating , Hepatitis Delta , Palo Alto , Eiger Biopharmaceuticals Daily , Nasdaq Eigr ,

Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Sees Large Growth in Short Interest

Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR – Get Rating) was the target of a significant increase in short interest in the month of April. As of April 15th, there was short interest totalling 2,710,000 shares, an increase of 9.3% from the March 31st total of 2,480,000 shares. Based on an average daily volume of 626,100 shares, the […] ....

Davida Cory , Glenns Jeffrey , Squarepoint Ops , Eiger Biopharmaceuticals Company Profile , Eiger Biopharmaceuticals Inc , Annandale Capital , Millennium Management , Eiger Biopharmaceuticals , Get Rating , Hepatitis Delta , Palo Alto , Eiger Biopharmaceuticals Daily , Nasdaq Eigr ,

Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Sees Significant Increase in Short Interest

Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR – Get Rating) was the recipient of a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 2,240,000 shares, an increase of 12.6% from the February 28th total of 1,990,000 shares. Based on an average daily trading volume, of 756,500 shares, […] ....

United States , Davida Cory , Thomas John Dietz , Glenns Jeffrey , Robertw Baird , Eiger Biopharmaceuticals Company Profile , Marshall Wace , Annandale Capital , Group Plc , America Corp , Eiger Biopharmaceuticals Inc , Eiger Biopharmaceuticals , Get Rating , Director Thomas John Dietz , General Group Plc , Hepatitis Delta , Palo Alto , Eiger Biopharmaceuticals Daily , Nasdaq Eigr ,

Eiger BioPharmaceuticals (NASDAQ:EIGR) Share Price Crosses Below Two Hundred Day Moving Average of $3.41

Shares of Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR – Get Rating) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $3.41 and traded as low as $0.95. Eiger BioPharmaceuticals shares last traded at $1.01, with a volume of 335,495 shares traded. Wall Street Analyst Weigh In A […] ....

United States , Davida Cory , Robertw Baird , Glenns Jeffrey , Thomas John Dietz , Eiger Biopharmaceuticals Company Profile , Marshall Wace , Eiger Biopharmaceuticals Inc , America Corp , Group Plc , Annandale Capital , Eiger Biopharmaceuticals , Get Rating , Director Thomas John Dietz , General Group Plc , Hepatitis Delta , Palo Alto , Eiger Biopharmaceuticals Daily , Nasdaq Eigr ,